Federal Bid

Last Updated on 07 May 2025 at 7 PM
Sources Sought
Frederick Maryland

RFI Novel Antimalarial Drug Targets

Solicitation ID PANDHA-25-P-0000-015601-RFI-Novel-Antimalarial-Drug-Targets
Posted Date 07 May 2025 at 7 PM
Archive Date 03 Jun 2025 at 4 AM
NAICS Category
Product Service Code
Set Aside No Set-Aside Used
Contracting Office Army Med Res Acq Activity
Agency Department Of Defense
Location Frederick Maryland United states 21702

This Request for Information (RFI)/Sources Sought (SS) Notice is for market research information and planning purposes only, and shall not be construed as a solicitation or as an obligation on the part of WRAIR, CIDR, VDB, or the Defense Health Agency (DHA) US Army Medical Research Acquisition Activity (USAMRAA).  

This non-commercial R&D requirement is expected to be a two-year study with a straight two-year Period of Performance (PoP) beginning September 30, 2025, and ending September 29, 2027.

The work to be performed under this contract shall be performed off-site at Contractor facilities that may be located anywhere in the Continental United States (CONUS).

See attached Request for information With DRAFT Statement of Work. 

Bid Protests Not Available

Similar Past Bids

Frederick Maryland 22 May 2025 at 8 PM
Location Unknown 17 Nov 2021 at 5 AM
Location Unknown 02 Dec 2022 at 5 AM
Institute West virginia 31 Dec 2003 at 5 AM

Similar Opportunities

Washington District of columbia 18 Oct 2027 at 8 PM
Washington District of columbia 18 Oct 2027 at 8 PM
Washington District of columbia 18 Oct 2027 at 8 PM
Washington District of columbia 18 Oct 2027 at 8 PM